The current state of bariatric endoscopy

McCarty, Thomas R.; Thompson, Christopher C.

doi:10.1111/den.13698

Cited by 23 publications

(15 citation statements)

References 69 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In Anlehnung an die Wirkungsweise des Roux-Y-Magenbypasses dienen Systeme zur endoskopischen Diversion der Umgehung von Teilen des Gastrointestinaltrakts [7,8]. Die Glukosehomöostase, aber auch die Steuerung von Sättigung, Appetit und Darmmotilität werden we-…”

Section: Endoskopische Diversionunclassified

“…7). Man bezeichnet die Prozedur daher auch als "endoskopische Schlauchmagen-Gastroplastie" (endoscopic sleeve gastroplasty, ESG) [7,8]. Der Nahtapparat wird an der Endoskopspitze befestigt und das Gewebe mit einem Instrument (Zange, Helix) gegriffen, das durch den Arbeits- Mittlerweile zeigten mehrere Studien mit relevanten Patientenzahlen für alle Systeme eine signifikante Gewichtsabnahme nach 12, z. T. 24 Monaten, bei keinen oder wenigen schwerwiegenden Nebenwirkungen (≤ 5 %).…”

Section: Endoskopische Nahtverfahrenunclassified

See 1 more Smart Citation

Endoskopische und chirurgische Therapie von Diabetes und Adipositas

Heer¹,

Mann²,

Wolter³

2021

Gastroenterologie up2date

View full text Add to dashboard Cite

Section: Endoskopische Diversionunclassified

Section: Endoskopische Nahtverfahrenunclassified

Endoskopische und chirurgische Therapie von Diabetes und Adipositas

Heer¹,

Mann²,

Wolter³

2021

Gastroenterologie up2date

View full text Add to dashboard Cite

“…2,3 Various devices and techniques have been developed so far in the field of EBMT, of which, intragastric balloons (IGBs) are the most popular and well-established. 4 Since its first trial in obesity in 1982, various IGBs with different characteristics have been commercialized worldwide. 5 Currently, three types of IGBs are available in Korea: End-ball (Endalis, Brignais, France), Orbera (Apollo Endosurgery, Inc., Austin, TX, USA), and Slim ball (CVBIO Co., Ltd., Seongnam, Korea), which are manufactured and sold by the Korean company CVBIO Co., Ltd.…”

Section: Introductionmentioning

confidence: 99%

Efficacy and safety of intragastric balloon for obesity in Korea

Lee¹,

Nam

Choi

et al. 2023

Clin Endosc

View full text Add to dashboard Cite

Background/Aims: Intragastric balloon (IGB) is the only available endoscopic bariatric and metabolic therapy in Korea. End-ball (Endalis) has the longest history of clinical use among the IGBs available in Korea. However, little clinical data on this system have been reported. In this study, we aimed to evaluate the efficacy and safety of End-ball in Korea. Methods: We performed a retrospective cohort study of patients who underwent IGB insertion (End-ball) from 2013 to 2019. Demographic and anthropometric data were collected. The efficacy and safety of IGB treatment were analyzed. Results: In total, 80 patients were included. Mean age was 33.7 years and 83.8% were female. Initial body mass index was 34.48±4.69 kg/m 2 . Body mass index reduction was 3.72±2.63 (kg/m 2 ) at the time of IGB removal. Percent of total body weight loss (%TBWL) was 10.76%±6.76%. Percentage excess body weight loss was 43.67%±27.59%. Most adverse events were minor, and 71.4% of participants showed nausea, vomiting, or abdominal pain. Conclusions: IGB treatment showed good efficacy and safety profile in Korean patients with obesity. In terms of %TBWL and percentage excess body weight loss, the efficacy was similar to that in the Western population.

show abstract

“…This classification is based on the methods registered in the USA by the FDA. On the other hand, there are numerous methods today that lack American FDA registration but are registered and approved within the European Union, or are approved in the context of experimental studies [18,19].…”

Section: Introductionmentioning

confidence: 99%

Endoscopic Treatment of Obesity and Nutritional Aspects of Bariatric Endoscopy

et al. 2021

View full text Add to dashboard Cite

Obesity is a significant problem worldwide. Several serious diseases that decrease patient quality of life and increase mortality (high blood pressure, dyslipidaemia, type 2 diabetes etc.) are associated with obesity. Obesity treatment is a multidisciplinary and complex process that requires maximum patient compliance. Change of lifestyle is fundamental in the treatment of obesity. While pharmacotherapeutic options are available, their efficacy is limited. Surgical treatment though highly effective, carries the risk of complications and is thus indicated mostly in advanced stages of obesity. Endoscopic treatments of obesity are less invasive than surgical options, and are associated with fewer complications and nutritional deficits. Currently, there is a large spectrum of endoscopic methods based on the principles of gastric volume reduction, size restriction and gastric or small bowel bypass being explored with only few available in routine practice. The aim of this publication is to present an up-to-date summary of available endoscopic methods for the treatment of obesity focusing on their efficacy, safety and nutritional aspects.

show abstract

The current state of bariatric endoscopy

Cited by 23 publications

References 69 publications

Endoskopische und chirurgische Therapie von Diabetes und Adipositas

Endoskopische und chirurgische Therapie von Diabetes und Adipositas

Efficacy and safety of intragastric balloon for obesity in Korea

Endoscopic Treatment of Obesity and Nutritional Aspects of Bariatric Endoscopy

Contact Info

Product

Resources

About